← All stories
Health, Longevity & Biohacking

Sharon Malone says oestrogen patch shortages need not halt hormone therapy

The Mel Robbins Podcast · #1 Hormone Doctor: The Ultimate Guide to Perimenopause, Fertility, Birth Control, PCOS, & Menopause · July 23, 2026
Sharon Malone says oestrogen patch shortages need not halt hormone therapy
The Mel Robbins Podcast
The Mel Robbins Podcast
#1 Hormone Doctor: The Ultimate Guide to Perimenopause, Fertility, Birth Control, PCOS, & Menopause
"The estrogen patch is not your only option. Systemic estrogen falls into two categories. Um there's transermal of which the patch is transermal, just means it just goes through the skin. So if you're out of patches, if you want to say, "Oh, but I really want to stay with the transermal," you can use a spray, you can use a gel."
Sharon Malone says reported shortages of oestrogen patches reflect rising demand that manufacturers should have anticipated. She advises patients to ask clinicians about transdermal options such as sprays or gels, different patch doses, or oral therapy depending on individual needs.

About this episode

Mel Robbins interviews Dr Sharon Malone, a US board-certified obstetrician-gynaecologist, for a wide-ranging explainer on women’s reproductive health from contraception through menopause. Malone argues that social media has fuelled fear about hormonal contraception and says birth control pills do not cause infertility; she also urges listeners not to treat cycle-tracking and other “natural” methods as reliable pregnancy prevention, particularly for people with irregular cycles. The discussion covers PCOS (which Malone says has been renamed by some to a broader metabolic label without changing diagnostic criteria), typical symptoms such as irregular periods, androgen excess and insulin resistance, and the limits of current understanding of underlying causes.

Malone outlines endometriosis as uterine-lining-like tissue growing outside the uterus, often missed on imaging and sometimes requiring laparoscopy to diagnose and treat; she says diagnostic delays can stretch for years and that the condition can contribute to infertility and painful sex. On fertility, she describes age-related decline accelerating after the mid-30s and encourages women to ask family members about menopause timing and reproductive history.

On menopause care, Malone characterises menopause as a long life stage affecting multiple systems, not a one-off event. She endorses hormone therapy as the most effective treatment for vasomotor symptoms and disputes the idea that it must be time-limited, while noting treatment should match symptoms and individual risk. She also addresses reported oestrogen patch shortages and alternatives, explains the difference between systemic and local vaginal oestrogen, and stresses resistance training and earlier attention to bone density around menopause.

Key takeaways

More stories More from The Mel Robbins Podcast